Several reports have shown that members of the ADAM family are overexpressed in human cancers such as ADAM8 in human renal cell carcinomas, ADAM15 in lung carcinoma, and ADAM17 in breast cancers (Mochizuki and Okada, 2007). This evidence concerns the gene ADAM17 and breast cancer.